Water soluble puerarin derivatives and preparation method and application thereof

A technology for puerarin derivatives and puerarin, which is applied in the directions of sugar derivatives, chemical instruments and methods, and compounds of elements of Group 5/15 of the periodic table, etc., can solve the problems of unstable preparations and poor water solubility of puerarin.

Active Publication Date: 2013-02-13
SHENZHEN JYMED TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In order to solve the problem of poor water solubility of puerarin and the instability of preparations caused by it, the purpose of the present invention is to design and synthesize prodrugs of highly water-soluble puerarin derivatives, mainly derivatives such as puerarin phosphate and sulfonate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Water soluble puerarin derivatives and preparation method and application thereof
  • Water soluble puerarin derivatives and preparation method and application thereof
  • Water soluble puerarin derivatives and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Dissolve 4.5 g (10.8 mmol) of puerarin (expressed in Formula 1) in 30 mL of dry pyridine, and slowly add 7.5 mL of acetic anhydride with stirring at room temperature. Stirring was continued at room temperature for 24 hours. Pyridine was evaporated under reduced pressure, and dilute HCl was added to adjust the pH to about 6. Use ethyl acetate, continue to stir for 24 hours, TLC tracking until the raw material point disappears (developing agent dichloromethane: methanol 9:1), evaporate pyridine under reduced pressure, add dilute HCl aqueous solution to adjust the pH value to 6, and extract with ethyl acetate , MgSO 4 After drying, filter, and evaporate to dryness of ethyl acetate to obtain a crude product, which was separated by column chromatography, the eluent was dichloromethane: methanol = 25:1, collected and evaporated to dryness to obtain 5.05 g of white powder acetyl puerarin (shown in formula 2). H1 NMR (CDCl3): δ8.20(d, J=8.0Hz, 1H), 8.00(s, 1H), 7.57(d, J=8.4H...

Embodiment 2

[0058] At room temperature, dissolve 5 g (7.48 mmol) of white powder acetyl puerarin (expressed in formula 2) in 100 mL of dry dichloromethane, slowly add 30 mL of saturated sodium bicarbonate solution and stir, TLC traces to the raw material Point disappears, adding appropriate amount of water, dichloromethane extraction, anhydrous Na 2 SO 4 After drying, it was filtered, and the filtrate was evaporated to dryness to obtain a crude product, which was purified by column chromatography with the elution condition of dichloromethane:methanol=45:1 to obtain 3.2 g of a white solid (shown in Formula 3), with a yield of 69.4%. H1NMR (CDCl3): δ8.30(br s, 1H), 8.21(d, J=8.8HZ, 1H), 7.99(s, 1H), 7.39(d, J=7.6HZ, 2H), 7.28(s, 1H), 7.03(d, J=8.8HZ, 1H), 6.89(d, J=7.6HZ, 2H), 5.99(br s, 1H), 5.48(m, 3H), 5.37(m, 1H), 4.40 (dd, J=8.0, 3.6HZ, 1H), 4.25(d, J=8.0Hz, 1H), 4.00(m, 1H), 2.16(s, 3H, 2, 12(s, 3H), 2.06(s , 3H), 1.71 (s, 3H).

Embodiment 3

[0060] Dissolve 1 gram of tetraacetylpuerarin (compound shown in formula 3) in dry pyridine, stir at room temperature, add 1.57 grams of phosphorus oxychloride (POCl 3 ), stirred for 24 hours after the addition; thin-layer detection tracked until the raw material point disappeared (the developing agent was dichloromethane:methanol==13:1, v / v), evaporated the pyridine, added an appropriate amount of water, and used 2N NaOH as the eluent The solution was neutralized to pH 7, the macroporous resin AB-8 was separated, eluted with pure water and collected, and the water was evaporated to dryness under reduced pressure to obtain 500 mg of tetrahydroxypuerarin phosphate white powder (shown in formula 4).

[0061] At room temperature, its solubility in water is greater than 200mg / 100ml. A certain amount of sample was mixed with rat anticoagulant plasma, incubated at 37°C, and the drug was extracted with acetonitrile at different time points for HPLC analysis. The half-life of puerarin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses water soluble puerarin derivatives shown in general formulas (I) and (II), a preparation method thereof, a medicinal composition containing one or more compound compositions, and application of the compounds in preparing medicaments for treating diseases such as cardiovascular and cerebrovascular diseases, retinal artery and vein occlusions, diabetes and the like.

Description

technical field [0001] The invention relates to puerarin, in particular to a water-soluble puerarin derivative and a preparation method and use thereof. Background technique [0002] Puerarin is a flavonoid glycoside extracted from the dried root of the perennial leguminous plant Pueraria lobata (Wil ld.) Ohwi or Pueraria thomsonii Benth. The chemical name is 7,4'-dihydroxy-8-β-D-glucose isoflavone, and the molecular formula is C 21 h 20 o 9 , molecular weight 416.38, CAS number 82373-94-2; as a unique component of kudzu root, it has a unique chemical structure, biological activity and pharmacological effects. Puerarin has the effect of dilating coronary arteries and cerebrovascular, has the functions of lowering blood sugar, blood fat, anti-oxidation, and improving hemorheology characteristics, so it is widely used in the treatment of clinical hypertension, coronary heart disease, acute cerebral infarction, diabetes and other diseases. [0003] The solubility of puerari...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D407/04C07F9/655A61K31/352A61P9/00A61P7/00C07H17/07
Inventor 张健存
Owner SHENZHEN JYMED TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products